AIQ
Caution
High confidence
ETF Comparison
A head-to-head comparison of Global X Artificial Intelligence & Technology ETF and Tema Healthcare AI ETF covering yield, cost, risk, and income potential.
Updated November 6, 2026
No track record yet. HLTH launched within the last six months. The forward distribution rate is left blank until a payout is published.
How these figures are calculated: methodology.
Compare the same available dates. Add a ticker or benchmark below; these controls change the chart only. The snapshot and article describe the original comparison.
Interactive history loads here. The snapshot and period returns remain available when chart history cannot be loaded.
An estimate of distribution reliability, not price or principal safety, a probability, or a guarantee. Score methodology.
Caution
High confidence
Not rated
No published distribution safety rating is available.
Score snapshot as of . Method 1.11.
| Metric | ||
|---|---|---|
| Full name | Global X Artificial Intelligence & Technology ETF | Tema Healthcare AI ETF |
| Issuer | Global X | Tema ETFs |
| Last Close | $56.89 as of November 6, 2026 | $26.95 as of November 6, 2026 |
| Distribution rate | 0.00% | — |
| Trailing 12-month yield | 0.08% | — |
| 30-day SEC yield | -0.07% | — |
| Distribution Safety Score™ | 52 | — |
| Safety-Adjusted Yield | 0.04% | — |
| Expense ratio | 0.68% | 0.75% |
| AUM | $9.57B | $11.7M |
| Distribution frequency | Semi-Annual | None |
| Underlying index | — | Actively managed (no tracked index recorded) |
| Objective | — | Seeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms. |
| Asset class | Equity | Equity |
| Inception date | 05/11/2018 | 07/21/2026 |
| Beta | 1.68 | — |
| Last dividend | $0.00045 | — |
| Ex-dividend date | 06/29/2026 | — |
— Distribution rate, Safety-Adjusted Yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.
100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year.
AIQ has outpaced HLTH over the year to date, posting a 10.40% total return against 5.60%. AIQ has been the steadier holding, though — annualized volatility of 28.5% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested.
| Symbol | YTD cumulative | Since Jul 2026 | Volatility | Sharpe | Sortino | Max drawdown |
|---|---|---|---|---|---|---|
| AIQ | 10.40% | -7.95% | 28.5% | -1.11 | -1.43 | -16.3% |
| HLTH | 5.60% | 5.60% | 35.9% | 0.39 | 0.52 | -12.6% |
Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of November 5, 2026. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year. “Since Jul 2026” measures every fund from July 21, 2026 — the start of shared available history — so all funds share one comparison window. Volatility is the annualized standard deviation of daily total returns over the shared window since Jul 2026. Sharpe and Sortino divide the annualized return in excess of the risk-free rate by, respectively, that volatility and the downside deviation (both over the shared window since Jul 2026) — higher is better. Max drawdown is the largest peak-to-trough total-return decline over the same window — shallower is better.
| Metric | AIQ | HLTH |
|---|---|---|
| Forward distribution rate | 0.00% | — |
| Trailing 12-month yield | 0.08% | — |
| 30-day SEC yield | -0.07% | — |
Total return (price change plus reinvested distributions) is the Total returns section above. A 30-day SEC yield can sit far from the headline distribution rate; both numbers are the fund's own published fields.
HLTH (Tema Healthcare AI ETF) has no distribution rate on file and its distribution frequency is None. HLTH is not a payer. The blank yield is not a zero yield.
Projections assume the current yield and share price remain constant. Actual results will vary.
Bottom lineWe won't call this one: HLTH launched July 2026, so there is not yet a track record to compare. Compare the strategy, cost and holdings in the sections above and treat any performance figures for the newer ETF as provisional.
See how much monthly income a hypothetical investment would generate in each ETF at current yields.
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
Global X is known for offering a diverse lineup of thematic and income-focused ETFs that cater to both traditional and alternative investment strategies. Their fund families span income generation through covered call strategies and SuperDividend funds, alongside thematic exposure in areas like digital assets, robotics, and emerging markets, complemented by bond and commodities offerings. The issuer provides broad coverage across sector-specific, risk-managed, and growth-oriented strategies, making their lineup particularly notable for investors seeking specialized exposure beyond conventional equity and fixed-income categories.
See our curated list of related YouTube videos on AIQ.
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
Tema ETFs is known for offering thematically focused and income-oriented strategies that target specific industries and trends rather than broad market exposure. The issuer's lineup spans both income-generating funds and thematic investments centered on sectors such as defense, healthcare, technology, and infrastructure, with tickers including ARMY, CANC, DSPY, HLTH, LAZR, NASA, and VOLT. Tema's approach appeals to investors seeking targeted exposure to niche market segments, combining specialized industry focus with dividend and yield strategies.
See our curated list of related YouTube videos on HLTH.
AIQ (Global X Artificial Intelligence & Technology ETF) and HLTH (Tema Healthcare AI ETF) are both ETFs, but they take different approaches.
AIQ is cheaper with an expense ratio of 0.68% compared to 0.75%.
AIQ has $9.57B in assets vs $11.7M for HLTH, but HLTH only launched July 2026 — AUM comparisons will become more meaningful as it builds a track record.
Positions that appear in every fund's top 10. Issuers disclose only the largest weights, so this captures the overlap of the concentrated end of each book — not the full portfolios.
No overlap among the top-10 disclosed holdings of AIQ, HLTH. These funds draw from largely different positions at the top of their books.
On a $10,000 investment at current distribution rates, AIQ has no reported distribution yield yet, so a cash estimate is not available, while HLTH has no reported distribution yield yet, so a cash estimate is not available.
Over 10 years on $10,000, AIQ would cost approximately $680 in fees vs $750 for HLTH (simplified, not compounded). The $70.00 difference may be offset by yield or performance.
AIQ is an ETF built around technology exposure, while HLTH is an actively managed ETF built around healthcare exposure.
AIQ is managed by Global X (launched 05/11/2018) with $9.57B in assets. HLTH is managed by Tema ETFs (launched 07/21/2026) with $11.7M in assets.
Neither AIQ nor HLTH currently reports a distribution yield, so neither is an income fund today. Compare them on holdings, cost, and total return instead.
AIQ (Global X Artificial Intelligence & Technology ETF) is an ETF built around technology exposure, while HLTH (Tema Healthcare AI ETF) is an actively managed ETF built around healthcare exposure. They are issued by Global X and Tema ETFs respectively.
Yes. Their disclosed top-10 holdings share no positions, so combining both spreads your money across different underlying names — see the holdings-overlap section above for the details. Overlap outside the disclosed top 10 can still exist.
AIQ has an expense ratio of 0.68% while HLTH charges 0.75%. Lower fees mean more of your investment returns stay in your pocket over time.
At current distribution rates, AIQ has not established a distribution history yet, so a cash estimate is not available. HLTH does not pay distributions, so there is no cash income to estimate.
AIQ has outpaced HLTH over the year to date, posting a 10.40% total return against 5.60%. AIQ has been the steadier holding, though — annualized volatility of 28.5% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.
Generated November 1, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
AIQ and HLTH are both equity ETFs focused on artificial intelligence, but they operate at dramatically different scales and with different sector focus. AIQ is a $9.57B technology-focused ETF that tracks companies across the broader AI ecosystem, while HLTH is an actively managed $11.7M healthcare-specific ETF that applies AI exposure exclusively to drug discovery, diagnostics, medical devices, and healthcare IT. The fundamental difference is breadth versus depth: AIQ casts a wide net across the AI sector; HLTH concentrates on a single vertical within healthcare.
AIQ holds a diversified basket of AI and technology companies and trades as a passive index strategy, while HLTH uses active management to select healthcare firms leveraging AI applications. AIQ's $9.57B asset base dwarfs HLTH's $11.7M, reflecting AIQ's established track record since 05/11/2018 versus HLTH's launch in 07/21/2026. AIQ generates no income (0.00% distribution rate), whereas HLTH reports no distributions. AIQ exhibits a 1.68 beta, reflecting meaningful sensitivity to broader market movements.
If you want diversified, liquid AI exposure with passive management and an established track record, AIQ's scale and 0.68% expense ratio are clearly advantageous. If you believe active managers can identify underappreciated healthcare-AI opportunities and accept concentration and fund-scale risk, HLTH's specialized mandate may merit investigation — though its $11.7M size and 07/21/2026 launch date mean it has minimal operating history. Past performance does not predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
The metrics behind this comparison, explained in the Academy.
These comparisons follow the Dividend Vision methodology.